Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.
- Author:
Li-juan FENG
1
,
2
;
Zhe WAN
;
Xiao-hong WANG
;
Ruo-yu LI
;
Wei LIU
Author Information
- Publication Type:Journal Article
- MeSH: Antifungal Agents; pharmacology; Candida albicans; drug effects; genetics; Cytochrome P-450 Enzyme System; genetics; Drug Resistance, Fungal; Fluconazole; pharmacology; Fungal Proteins; genetics; Microbial Sensitivity Tests; Mutation
- From: Chinese Medical Journal 2010;123(5):544-548
- CountryChina
- Language:English
-
Abstract:
BACKGROUNDThe cytochrome P450 lanosterol 14alpha-demethylase (Erg11p) encoded by ERG11 gene is the primary target for azole antifungals. Changes in azole affinity of this enzyme caused by amino acid substitutions have been reported as a mechanism of azole antifungal resistance. This study aimed to investigate the relationship between amino acid substitutions in Erg11p from fluconazole resistant Candida albicans (C. albicans) isolates and their cross-resistance to azoles.
METHODSMutations in ERG11 gene were screened in 10 clinical isolates of fluconazole resistant C. albicans strains. DNA sequence of ERG11 was determined by PCR based DNA sequencing.
RESULTSIn the 10 isolates, 19 types of amino acid substitutions were found, of which 10 substitutions (F72S, F103L, F145I, F198L, G206D, G227D, N349S, F416S, F422L and T482A) have not been reported previously. Mutations in ERG11 gene were detected in 9 isolates of fluconazole resistant C. albicans, but were not detected in 1 isolate.
CONCLUSIONSAlthough no definite correlation was found between the type of amino acid substitutions in Erg11p and the phenotype of cross-resistance to azoles, the substitutions F72S, F145I and G227D in our study may be highly associated with resistance to azoles because of their special location in Erg11p.
